학술논문
Bictegravir-Induced Drug Reaction With Eosinophilia and Systemic Symptoms in a Patient With Acute Human Immunodeficiency Virus
Document Type
Academic Journal
Author
Source
Open Forum Infectious Diseases. March, 2023, Vol. 10 Issue 3
Subject
Language
English
Abstract
Although drug reaction with eosinophilia and systemic symptoms (DRESS) is associated with antiretrovirals, there are no published reports of bictegravir-induced DRESS. Bictegravir is recommended as first-line treatment for patients with human immunodeficiency virus (HIV). Recognition of DRESS, its skin manifestations, and potential complications is vital for appropriate care and management of acute HIV. Keywords. antiretroviral therapy; bictegravir; DRESS; drug reaction with eosinophilia and systemic symptoms; HIV.
Drug reaction with eosinophilia and systemic symptoms (DRESS) is a potentially life-threatening condition characterized by severe skin exanthem, fever, atypical lymphocytosis, marked eosinophilia, and, less commonly, multiorgan involvement [1]. It [...]
Drug reaction with eosinophilia and systemic symptoms (DRESS) is a potentially life-threatening condition characterized by severe skin exanthem, fever, atypical lymphocytosis, marked eosinophilia, and, less commonly, multiorgan involvement [1]. It [...]